Atherosclerotic lesions arise following severe inflammatory response to a variety of insults. The abnormal pathology associated with this disease likely arises from an abnormal growth factor and cytokine expression, excessive cellular processing of lipoproteins, and altered proteinase activity, all of which result in increased smooth muscle cell migration and proliferation. The low density lipoprotein receptor related protein (LRP) is a large endocytic multi-ligand receptor that mediates the hepatic uptake of circulating chylomicron remnants, serpin- enzyme complexes, and proteinases of the fibrinolytic pathway. LRP is expressed not only in hepatocytes, but also in macrophages, smooth muscle cells, fibroblasts, and neurons, suggesting that it is involved in the binding and removal of interstitial ligands (eg. proteinases and lipoproteins) produced by these cells. A 39 kDa receptor associated protein (RAP) binds reversibly to LRP and antagonizes its ligand binding. RAP is found primarily in the endoplasmic reticulum, where it is thought to function as a molecular chaperone for LRP, gp330/megalin, and the VLDL receptor. The central hypothesis of this application is that regulation of proteinase activity and lipoprotein levels by LRP represents an important physiological pathway, and that the activity of LRP contributes to certain processes such as cell migration and to the pathology of certain diseases such as atherosclerosis. The specific hypotheses to be tested are: 1) That RAP modulates ligand binding to LRP by an allosteric mechanism 2) that RAP plays an important role in the expression of LRP activity by minimizing ligand-induced LRP degradation 3) that LRP may regulate cell surface proteinase activity, and 4) that LRP activity is regulated by its phosphorylation. These hypothesis will be tested in the following aims: 1. Identify the regions on LRP responsible for RAP and ligand binding 2. Define the mechanism of ligand induced degradation of LRP and the role of RAP in minimizing this process 3. Define the mechanisms by which LRP regulates cellular proteinase activity, and determine the contribution of this pathway to such processes as cell migration. 4. Determine if LRP is phosphorylated and if so, define the significance of this phosphorylation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL050784-06
Application #
2693340
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-09-30
Project End
2002-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Strickland, Dudley K; Muratoglu, Selen C (2016) LRP in Endothelial Cells: A Little Goes a Long Way. Arterioscler Thromb Vasc Biol 36:213-6
Wahler, Anke; Beyer, Anja-Silke; Keller, Ilona E et al. (2013) Engulfment adaptor phosphotyrosine-binding-domain-containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and is transactivationally active together with low-density lipoprotein receptor-related protein 1 (LRP1). Biochem J 450:333-43
Craig, Julie; Mikhailenko, Irina; Noyes, Nathaniel et al. (2013) The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events. PLoS One 8:e70432
Muratoglu, Selen C; Belgrave, Shani; Hampton, Brian et al. (2013) LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1. Arterioscler Thromb Vasc Biol 33:2137-46
Yakovlev, Sergiy; Mikhailenko, Irina; Cao, Chunzhang et al. (2012) Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes. Blood 119:637-44
Ranganathan, Sripriya; Cao, Chunzhang; Catania, Jason et al. (2011) Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1. J Biol Chem 286:30535-41
Ranganathan, Sripriya; Noyes, Nathaniel C; Migliorini, Mary et al. (2011) LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking. J Neurosci 31:10836-46
Strickland, Dudley K; Muratoglu, Selen Catania; Antalis, Toni M (2011) Serpin-Enzyme Receptors LDL Receptor-Related Protein 1. Methods Enzymol 499:17-31
Muratoglu, Selen Catania; Belgrave, Shani; Lillis, Anna P et al. (2011) Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-? signaling pathway. PLoS One 6:e28846
Meng, He; Zhang, Xiaojie; Lee, Soo Jung et al. (2010) Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin-2 (TSP2) enhancement of Notch3 signaling. J Biol Chem 285:23047-55

Showing the most recent 10 out of 64 publications